These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 31584927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method.
    El Amrani M, van den Broek MP, Göbel C, van Maarseveen EM.
    J Chromatogr A; 2016 Jul 08; 1454():42-8. PubMed ID: 27264745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
    Jourdil JF, Lebert D, Gautier-Veyret E, Lemaitre F, Bonaz B, Picard G, Tonini J, Stanke-Labesque F.
    Anal Bioanal Chem; 2017 Feb 08; 409(5):1195-1205. PubMed ID: 27826630
    [Abstract] [Full Text] [Related]

  • 5. A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
    Willeman T, Jourdil JF, Gautier-Veyret E, Bonaz B, Stanke-Labesque F.
    Anal Chim Acta; 2019 Aug 27; 1067():63-70. PubMed ID: 31047150
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
    Truffot A, Jourdil JF, Seitz-Polski B, Malvezzi P, Brglez V, Stanke-Labesque F, Gautier-Veyret E.
    Clin Biochem; 2021 Jan 27; 87():60-66. PubMed ID: 33096054
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum.
    Iwamoto N, Yokoyama K, Takanashi M, Yonezawa A, Matsubara K, Shimada T.
    Curr Pharm Biotechnol; 2018 Jan 27; 19(6):495-505. PubMed ID: 29968534
    [Abstract] [Full Text] [Related]

  • 10. Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods.
    Tron C, Lemaitre F, Bros P, Goulvestre C, Franck B, Mouton N, Bagnos S, Coriat R, Khoudour N, Lebert D, Blanchet B.
    Bioanalysis; 2022 Jun 27; 14(11):831-844. PubMed ID: 35735172
    [Abstract] [Full Text] [Related]

  • 11. Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levels.
    Ogrič M, Žigon P, Drobne D, Štabuc B, Sodin-Semrl S, Čučnik S, Praprotnik S.
    Immunol Res; 2018 Dec 27; 66(6):726-736. PubMed ID: 30569379
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Agreement in assessment of infliximab and adalimumab levels in rheumatoid arthritis: interlaboratory and interassay comparison.
    Valor L, Hernández-Flórez D, de la Torre I, Llinares F, Rosas J, Yagüe J, Garrido J, Naredo E.
    Clin Exp Rheumatol; 2015 Dec 27; 33(5):617-23. PubMed ID: 26316061
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.
    Barclay ML, Karim S, Helms ETJ, Keating PE, Hock B, Stamp LK, Schultz M.
    Intern Med J; 2019 Apr 27; 49(4):513-518. PubMed ID: 30091273
    [Abstract] [Full Text] [Related]

  • 18. Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
    Afonso J, Lopes S, Gonçalves R, Caldeira P, Lago P, Tavares de Sousa H, Ramos J, Gonçalves AR, Ministro P, Rosa I, Vieira AI, Dias CC, Magro F, Portuguese IBD Study Group (GEDII).
    Aliment Pharmacol Ther; 2016 Oct 27; 44(7):684-92. PubMed ID: 27507790
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.